United States Antimony Corporation UAMY
4.50
(0.07)
(1.53%)
as of 25 Sep
- Market cap
- $693.0M
- P/E
- 0.0×
Follow UAMY
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
29.21 | 31.67 | 15.81 | 24.02 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(122.90) | (102.51) | (178.85) | (198.04) | |
P/B ratio |
5.88 | 9.37 | 4.40 | 10.67 | |
Price to Tangible BV |
5.88 | 9.37 | 4.40 | 10.67 | |
EV/Sales |
27.95 | 31.47 | 14.92 | 23.41 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(36.31) | (61.36) | (60.44) | (147.90) | |
EV/FCF |
(14.29) | (20.64) | (15.63) | (35.00) | |
Quick Ratio |
7.33 | 1.74 | 3.86 | 3.43 | |
Current Ratio |
11.54 | 3.62 | 5.38 | 5.08 | |
Net Debt/EBITDA |
7.11 | 1.09 | 9.92 | 4.14 | |
Debt/Assets |
0.18% | 0.11% | 0.13% | 0.29% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.31 | 0.42 | 0.42 | 0.58 | |
Operating CF/Net income |
(79.89) | 1.07 | 12.02 | 0.81 | |
Capex/Depreciation |
(18.67) | (28.40) | (28.97) | (35.98) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
87.36% | 125.19% | 46.34% | 72.92% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
36.65% | 71.25% | 18.36% | 44.32% | |
Graham Net Nets |
0.06 | 0.03 | 0.07 | 0.03 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(1.68%) | (1.39%) | (0.73%) | (0.67%) | |
Free Cash Flow Yield |
(6.70%) | (4.82%) | (6.04%) | (2.78%) | |
Revenue per Share |
0.05 | 0.05 | 0.11 | 0.07 | |
Operating CF per Share |
(0.06) | (0.09) | (0.03) | (0.03) | |
Capex per Share |
(0.07) | (0.09) | (0.09) | (0.07) | |
Free Cash Flow per Share |
(0.13) | (0.17) | (0.12) | (0.10) | |
Cash per Share |
0.31 | 0.06 | 0.28 | 0.16 | |
Shareholders Equity per Share |
1.23 | 0.93 | 1.14 | 0.58 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.23 | 0.93 | 1.14 | 0.58 | |
Free Cash Flow |
(18.89) | (24.64) | (15.20) | (12.53) | |
Working Capital |
69.99 | 35.04 | 44.56 | 25.54 | |
Capital Expenditures |
(10.23) | (12.58) | (11.73) | (8.67) | |
Net Current Asset Value |
67.03 | 32.25 | 41.77 | 23.67 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
1.29 | 1.85 | 0.90 | 1.00 | |
Net Profit Margin |
1.37% | (166.51%) | (2.22%) | (54.96%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.58 | 8.67 | 2.66 | 1.34 | |
Average Payables |
4.84 | 6.44 | 4.24 | 2.72 | |
Average Inventory |
14.21 | 13.01 | 6.88 | 4.69 | |
Average Assets |
119.06 | 93.77 | 94.28 | 54.82 | |
Average Common Equity |
109.25 | 82.23 | 84.77 | 48.43 |
Columns are period end dates